Bank of Montreal’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.3M | Buy |
242,063
+2,798
| +1% | +$613K | 0.02% | 557 |
|
|
2026
Q1 | $45.2M | Buy |
239,265
+15,944
| +7% | +$2.79M | 0.02% | 578 |
|
|
2025
Q4 | $38M | Sell |
223,321
-113,841
| -34% | -$17.5M | 0.01% | 651 |
|
|
2025
Q3 | $44.4M | Buy |
337,162
+8,687
| +3% | +$1.04M | 0.02% | 530 |
|
|
2025
Q2 | $34.9M | Buy |
328,475
+201,008
| +158% | +$21.8M | 0.02% | 550 |
|
|
2025
Q1 | $15.8M | Buy |
127,467
+110,273
| +641% | +$14.4M | 0.01% | 779 |
|
|
2024
Q4 | $2.12M | Sell |
17,194
-2,253
| -12% | -$266K | ﹤0.01% | 1522 |
|
|
2024
Q3 | $2.16M | Sell |
19,447
-49,214
| -72% | -$5.39M | ﹤0.01% | 1675 |
|
|
2024
Q2 | $7.46M | Sell |
68,661
-20,852
| -23% | -$2.29M | ﹤0.01% | 1124 |
|
|
2024
Q1 | $10.8M | Sell |
89,513
-7,058
| -7% | -$865K | ﹤0.01% | 944 |
|
|
2023
Q4 | $11.9M | Sell |
96,571
-51,176
| -35% | -$6.39M | ﹤0.01% | 963 |
|
|
2023
Q3 | $19.9M | Sell |
147,747
-7,802
| -5% | -$1.04M | 0.01% | 715 |
|
|
2023
Q2 | $20M | Buy |
155,549
+58,020
| +59% | +$7.81M | 0.01% | 742 |
|
|
2023
Q1 | $14.3M | Buy |
97,529
+5,376
| +6% | +$795K | 0.01% | 792 |
|
|
2022
Q4 | $14.7M | Buy |
92,153
+78,505
| +575% | +$11.5M | 0.01% | 814 |
|
|
2022
Q3 | $1.87K | Sell |
13,648
-469
| -3% | -$71.3K | ﹤0.01% | 1849 |
|
|
2022
Q2 | $2.21K | Sell |
14,117
-3,309
| -19% | -$509K | ﹤0.01% | 1847 |
|
|
2022
Q1 | $2.78M | Sell |
17,426
-90,820
| -84% | -$13.2M | ﹤0.01% | 1758 |
|
|
2021
Q4 | $14M | Sell |
108,246
-51,194
| -32% | -$6.73M | 0.01% | 857 |
|
|
2021
Q3 | $21.1M | Sell |
159,440
-349,318
| -69% | -$52.8M | 0.01% | 906 |
|
|
2021
Q2 | $92.8M | Sell |
508,758
-1,994
| -0.4% | -$345K | 0.05% | 323 |
|
|
2021
Q1 | $82.2M | Buy |
510,752
+25,585
| +5% | +$4.21M | 0.05% | 298 |
|
|
2020
Q4 | $78.5M | Sell |
485,167
-146,828
| -23% | -$21.9M | 0.05% | 301 |
|
|
2020
Q3 | $89M | Sell |
631,995
-79,252
| -11% | -$9.83M | 0.07% | 221 |
|
|
2020
Q2 | $75M | Sell |
711,247
-26,353
| -4% | -$2.91M | 0.07% | 240 |
|
|
2020
Q1 | $73.4M | Sell |
737,600
-150,930
| -17% | -$19.5M | 0.08% | 198 |
|
|
2019
Q4 | $133M | Buy |
888,530
+699,002
| +369% | +$95.1M | 0.1% | 183 |
|
|
2019
Q3 | $24.3M | Buy |
189,528
+25,876
| +16% | +$3.47M | 0.02% | 562 |
|
|
2019
Q2 | $23.3M | Buy |
163,652
+24,996
| +18% | +$3.36M | 0.02% | 597 |
|
|
2019
Q1 | $19.8M | Buy |
138,656
+33,895
| +32% | +$4.42M | 0.02% | 607 |
|
|
2018
Q4 | $13M | Buy |
104,761
+6,034
| +6% | +$895K | 0.01% | 695 |
|
|
2018
Q3 | $16.6M | Buy |
98,727
+57,266
| +138% | +$9.85M | 0.01% | 716 |
|
|
2018
Q2 | $7.14M | Buy |
41,461
+4,260
| +11% | +$696K | 0.01% | 1015 |
|
|
2018
Q1 | $5.62M | Sell |
37,201
-112
| -0.3% | -$16.4K | 0.01% | 1101 |
|
|
2017
Q4 | $5.03M | Sell |
37,313
-18,091
| -33% | -$2.51M | ﹤0.01% | 1128 |
|
|
2017
Q3 | $8.1M | Buy |
55,404
+9,673
| +21% | +$1.46M | 0.01% | 944 |
|
|
2017
Q2 | $7.11M | Sell |
45,731
-39
| -0.1% | -$5.96K | 0.01% | 1002 |
|
|
2017
Q1 | $6.64M | Buy |
45,770
+28,904
| +171% | +$3.76M | 0.01% | 957 |
|
|
2016
Q4 | $1.75M | Sell |
16,866
-5,821
| -26% | -$648K | ﹤0.01% | 1636 |
|
|
2016
Q3 | $2.76M | Sell |
22,687
-24,063
| -51% | -$3.24M | ﹤0.01% | 1347 |
|
|
2016
Q2 | $6.61M | Buy |
46,750
+16,907
| +57% | +$2.49M | 0.01% | 982 |
|
|
2016
Q1 | $3.9M | Buy |
29,843
+854
| +3% | +$106K | ﹤0.01% | 1132 |
|
|
2015
Q4 | $4.07M | Buy |
28,989
+75
| +0.3% | +$10.4K | ﹤0.01% | 1078 |
|
|
2015
Q3 | $3.84M | Buy |
28,914
+611
| +2% | +$105K | 0.01% | 1046 |
|
|
2015
Q2 | $4.98M | Sell |
28,303
-3,673
| -11% | -$660K | 0.01% | 1060 |
|
|
2015
Q1 | $5.53M | Sell |
31,976
-1,474
| -4% | -$253K | 0.01% | 1011 |
|
|
2014
Q4 | $5.48M | Sell |
33,450
-2,295
| -6% | -$381K | 0.01% | 1009 |
|
|
2014
Q3 | $5.74M | Sell |
35,745
-4,992
| -12% | -$768K | 0.01% | 1031 |
|
|
2014
Q2 | $5.99M | Sell |
40,737
-288,607
| -88% | -$40M | 0.01% | 1021 |
|
|
2014
Q1 | $45.7M | Sell |
329,344
-27,969
| -8% | -$4.21M | 0.06% | 245 |
|
|
2013
Q4 | $45.2M | Buy |
357,313
+65,181
| +22% | +$6.74M | 0.06% | 232 |
|
|
2013
Q3 | $26.9M | Buy |
292,132
+23,124
| +9% | +$1.87M | 0.04% | 288 |
|
|
2013
Q2 | $18.5M | Buy |
+269,008
| New | +$16.4M | 0.03% | 328 |
|
Other funds holding JAZZ
VPM
VCM
Bank of Montreal's JAZZ Position: Q2 2026 in Review
Bank of Montreal increased its Jazz Pharmaceuticals (JAZZ) stake by 1.2% in Q2 2026, buying an estimated $613K and bringing the position to 242,063 shares worth $58.3M. The position accounts for 0.02% of the portfolio, ranked #557.
Bank of Montreal first reported a position in JAZZ in Q2 2013 and has held it in 53 quarters since. The position peaked at $133M in Q4 2019. 491 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Bank of Montreal held 242,063 shares of Jazz Pharmaceuticals worth $58.3M as of Q2 2026.
- Bank of Montreal bought 2,798 Jazz Pharmaceuticals shares in Q2 2026, an estimated $613K.
- Jazz Pharmaceuticals made up 0.02% of Bank of Montreal's portfolio in Q2 2026, its #557 holding.
- Bank of Montreal first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Jazz Pharmaceuticals position peaked at $133M in Q4 2019.
- 491 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.